Chase C. Leavitt - 27 Jan 2022 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Role
General Counsel/Secretary
Signature
/s/Chase C. Leavitt
Issuer symbol
N/A
Transactions as of
27 Jan 2022
Net transactions value
+$23,280
Form type
4
Filing time
31 Jan 2022, 15:00:18 UTC
Previous filing
24 Jan 2022
Next filing
01 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $15,130 +8,500 +27% $1.78 39,867 27 Jan 2022 Direct
transaction ONCT Common Stock Purchase $8,150 +5,000 +13% $1.63 44,867 28 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.